Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18517289 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Luteal Phase Administration of Paroxetine for the Treatment of PMDD
Condition: Premenstrual Dysphoric Disorder
Intervention: Drug: Paroxetine

Study has passed its completion date and status has not been verified in more than two years.